source Post navigation Breakthrough T1D supports Integrated Nanotherapeutics’ tolerizing therapy for type 1 diabetes – BioWorld Online Lexicon Pharma (LXRX): New Secondary Analysis of Phase 3 Data Demonstrates Sotagliflozin Improves TIR and Several Parameters of Glucose Control and Variability in Basal Insulin-Treated Type 2 Diabetes – StreetInsider.com